T2w subtraction MR imaging in phase II MS trials: a powerful new outcome measure

B. Moraal, I.J. van den Elskamp, D.L. Knol, B.M.J. Uitdehaag, J.J.G. Geurts, H. Vrenken, P.J.W. Pouwels, R.A. van Schijndel, D. Meier, C.R. Guttmann, F. Barkhof

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)S8-S8
JournalMultiple Sclerosis
Volume15
Issue number9
Publication statusPublished - 2009

Cite this

Moraal, B. ; van den Elskamp, I.J. ; Knol, D.L. ; Uitdehaag, B.M.J. ; Geurts, J.J.G. ; Vrenken, H. ; Pouwels, P.J.W. ; van Schijndel, R.A. ; Meier, D. ; Guttmann, C.R. ; Barkhof, F. / T2w subtraction MR imaging in phase II MS trials: a powerful new outcome measure. In: Multiple Sclerosis. 2009 ; Vol. 15, No. 9. pp. S8-S8.
@article{72f0d82afb954dc5bd9618be005f6efd,
title = "T2w subtraction MR imaging in phase II MS trials: a powerful new outcome measure",
author = "B. Moraal and {van den Elskamp}, I.J. and D.L. Knol and B.M.J. Uitdehaag and J.J.G. Geurts and H. Vrenken and P.J.W. Pouwels and {van Schijndel}, R.A. and D. Meier and C.R. Guttmann and F. Barkhof",
year = "2009",
language = "Undefined/Unknown",
volume = "15",
pages = "S8--S8",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "9",

}

T2w subtraction MR imaging in phase II MS trials: a powerful new outcome measure. / Moraal, B.; van den Elskamp, I.J.; Knol, D.L.; Uitdehaag, B.M.J.; Geurts, J.J.G.; Vrenken, H.; Pouwels, P.J.W.; van Schijndel, R.A.; Meier, D.; Guttmann, C.R.; Barkhof, F.

In: Multiple Sclerosis, Vol. 15, No. 9, 2009, p. S8-S8.

Research output: Contribution to journalMeeting AbstractOther research output

TY - JOUR

T1 - T2w subtraction MR imaging in phase II MS trials: a powerful new outcome measure

AU - Moraal, B.

AU - van den Elskamp, I.J.

AU - Knol, D.L.

AU - Uitdehaag, B.M.J.

AU - Geurts, J.J.G.

AU - Vrenken, H.

AU - Pouwels, P.J.W.

AU - van Schijndel, R.A.

AU - Meier, D.

AU - Guttmann, C.R.

AU - Barkhof, F.

PY - 2009

Y1 - 2009

M3 - Meeting Abstract

VL - 15

SP - S8-S8

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 9

ER -